Disequilibria in the Distribution ofrpoBAlleles in Rifampicin-ResistantM. tuberculosisIsolates from Germany and Sierra Leone
- 1 January 1997
- journal article
- research article
- Published by Mary Ann Liebert Inc in Microbial Drug Resistance
- Vol. 3 (2) , 195-197
- https://doi.org/10.1089/mdr.1997.3.195
Abstract
The effectiveness of culture-independent resistance predictions by molecular techniques is dependent on the number and the frequency of accessible resistance-associated genomic mutations. We have characterized an rpoB gene region involved in rifampicin resistance in 49 Mycobacterium tuberculosis isolates resistant to rifampicin from Germany and Sierra Leone. The determined frequencies of mutations differed between both countries of origins as well as with respect to previously reported distributions of resistance mutations. It is concluded that at least for some isolates the acquisition of mutations leading to rifampicin resistance in clinical samples of M. tuberculosis is a non-random process which may lead to a geographical and temporal dependence of the sensitivities of molecular typing techniques for rifampicin resistance predictions.Keywords
This publication has 13 references indexed in Scilit:
- Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in JapanAntimicrobial Agents and Chemotherapy, 1996
- Mutation position and type of substitution in the β-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosisJournal of Antimicrobial Chemotherapy, 1995
- Detection of Rifampin Resistance among Isolates ofMycobacterium tuberculosisfrom MozambiqueMicrobial Drug Resistance, 1995
- Characterization of rifampin-resistance in pathogenic mycobacteriaAntimicrobial Agents and Chemotherapy, 1994
- Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular studyThe Lancet, 1994
- DNA fingerprints of Mycobacterium tuberculosis do not change during the development of rifampicin resistanceTubercle and Lung Disease, 1993
- Detection of rifampicin-resistance mutations in Mycobacterium tuberculosisThe Lancet, 1993
- Alteration of ribosomes and RNA polymerase in drug-resistant clinical isolates of Mycobacterium tuberculosisAntimicrobial Agents and Chemotherapy, 1985
- The pattern of resistance development to rifampicin in mycobacterium tuberculosisTubercle, 1972